PDCD1 and neoplasm: Further studies found that the phagocytosis ability of PD-1+ TAMs was significantly reduced while blocking PD-1/PD-L1 signaling could promote the phagocytosis of macrophages to tumor cells and enhance the macrophage dependent anti-tumor immune response (138, 139).